Delivery Order SPE2DB25D3020-SPE2DB25FWJWT
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $9,864.24 to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injector pens, with a completion deadline of August 20, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Repatha is a prescription medication used to treat high cholesterol, and this delivery order represents a routine...
- The Defense Logistics Agency awarded a delivery order valued at $13,727.57 to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injector pens. This non-competitive, firm fixed-price delivery order was awarded on September 9, 2025, with a completion date of September 10, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Repatha (evolocumab) is a PCSK9 inhibitor used to lower cholesterol and reduce cardiovascular risk in eligible...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,594.36 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injector pens on September 22, 2025, with an ultimate completion date of September 23, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania facility. Repatha is a prescription medication used to lower cholesterol levels and reduce the...
- The Defense Logistics Agency awarded a $19,632.10 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injector pens under contract 4569852163. This non-competitive, firm fixed-price delivery order was issued on October 28, 2025, with an ultimate completion date of October 29, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Repatha is a PCSK9 inhibitor used to treat high cholesterol...
- The Defense Logistics Agency awarded a $7,931.56 delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Repatha 140 mg/ml SureClick auto-injector pens. This is a firm fixed price, non-set-aside contract with an ultimate completion date of November 5, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. Repatha is a prescription medication used to lower cholesterol levels in patients with cardiovascular disease,...
- The Defense Logistics Agency awarded a delivery order valued at $2,603.55 to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injectors, with an ultimate completion date of August 4, 2025. This non-competitive delivery order represents a firm fixed-price transaction executed on August 1, 2025, with the product to be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Repatha is a prescription medication used to lower cholesterol levels and...
- The Defense Logistics Agency awarded a delivery order valued at $6,515.15 to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injector pens, with a completion date of September 2, 2025. This competitive award, issued on August 29, 2025, utilizes firm fixed pricing and carries no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Repatha is a prescription medication used to treat high cholesterol and...
- The Defense Logistics Agency awarded a delivery order valued at $5,390.03 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors. This competitive award, issued on June 2, 2025, with an ultimate completion date of June 3, 2025, represents a firm fixed-price transaction with no set-aside designation. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Repatha is a PCSK9 inhibitor used to treat high cholesterol and...
- The Defense Logistics Agency awarded a delivery order valued at $18,803.69 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with performance in Conshohocken, Pennsylvania and completion targeted for October 23, 2025. This non-set-aside, competitively awarded delivery order employs firm fixed price terms and represents a single transaction under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. Repatha is a prescription...
- The Defense Logistics Agency awarded a delivery order valued at $40,273.98 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors. This firm fixed price, non-set-aside contract was awarded on August 25, 2025, with an ultimate completion date of August 26, 2025. The pharmaceutical products will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. Repatha is a PCSK9 inhibitor used to treat high...
- SPE2DB25D3020Indefinite Delivery Contract
- SPE2DB25D3020-SPE2DB25FWJWTDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $10,015.20 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick autoinjector pens, with an ultimate completion date of August 7, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor's corporate office location in Conshohocken, Pennsylvania. Repatha is a PCSK9 inhibitor indicated for cardiovascular disease management, representing a specialty pharmaceutical product within the company's broader federal medical supply portfolio. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies to military healthcare programs and other federal healthcare systems worldwide. AmerisourceBergen's substantial contract volume with DLA reflects its established capability as a major pharmaceutical distributor meeting federal procurement requirements for military and veteran healthcare needs across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.0k | 8/6/25 |